Dr Charles Kelly
Dr Laura McKenzie
Nick West
| Squamous cell carcinoma of the posterior pharyngeal wall: A comparative analysis of oropharyngeal origin versus hypopharyngeal origin | 2024 |
|
Dr Charles Kelly
| Timing of development of osteoradionecrosis post head and neck radiotherapy: does a safe time interval exist for dental extraction? | 2024 |
|
Dr Santu Saha
Rachel Howarth
Dr Sweta Sharma Saha
Dr Charles Kelly
| Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer | 2023 |
|
Dr Charles Kelly
Michael Jackson
Nick West
Dr Naomi Willis
| Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck Cancer | 2023 |
|
Dr Charles Kelly
| Are taxanes more effective than 5FU in combination chemotherapy for recurrent and metastatic head and neck cancer? | 2022 |
|
Dr Chang Lee
Dr Charles Kelly
Mani Ragbir
Daniel Saleh
| Postoperative radiotherapy delay in head and neck cancer patients undergoing major resection and free flap reconstruction | 2022 |
|
Dr Shahid Iqbal
James O'Hara
Dr Charles Kelly
| Survival outcomes for patients with nasopharyngeal carcinoma in non–endemic region in the UK treated with intensity modulated based radiotherapy 65 Gy in 30 fractions ± weekly cisplatin chemotherapy | 2022 |
|
Dr Shahid Iqbal
Dr Charles Kelly
Dr Santu Saha
James O'Hara
David Hamilton
et al. | Survival outcomes of parotid carcinoma treated with surgery and radiotherapy or radiotherapy alone | 2022 |
|
James O'Hara
David Hamilton
Dr David Meikle
Dr Charles Kelly
Professor Vinidh Paleri
et al. | Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma—A large observational single-centre series from the United Kingdom | 2021 |
|
Dr Charles Kelly
| Response to “Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma”—Does it require to irradiate neck in pN0 disease? | 2021 |
|
Nick West
Neil Richmond
David Morgan
Professor Vinidh Paleri
Dr Charles Kelly
et al. | A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer | 2020 |
|
Professor Vinidh Paleri
Dr Charles Kelly
| De-intensification of treatment in human papilloma virus related oropharyngeal carcinoma: Patient choice still matters for de-escalation and for the COVID era | 2020 |
|
Mohammad Iqbal
Dr Charles Kelly
| Is it Time to Have a Further Debate on Separating Radiation and Medical Oncology Specialties Rather than Continue the Clinical Oncology Model? | 2019 |
|
Dr Charles Kelly
| Adjuvant bevacizumab for melanoma patients at high risk of recurrence: Survival analysis of the AVAST-M trial | 2018 |
|
Dr David Meikle
Dr Charles Kelly
Professor Vinidh Paleri
James O'Hara
| Contralateral neck metastases in lateralised, resectable advanced stage oropharyngeal squamous cell carcinoma—Results of 57 patients undergoing bilateral selective neck dissection | 2018 |
|
Dr Charles Kelly
Dr Michael Drinnan
Professor Vinidh Paleri
| Extreme long-term voice outcomes after concurrent chemoradiotherapy for advanced non-laryngeal head and neck cancer: Eight-year post-treatment analysis | 2018 |
|
Dr Charles Kelly
Dr Hazel McCallum
Dr Rachel Pearson
| Guidelines & recommendations: UK quantitative WB-DWI technical workgroup: Consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer | 2018 |
|
Dr Charles Kelly
Bojidar Goranov
David Morgan
Professor Vinidh Paleri
| Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A survey of UK national practice | 2018 |
|
Dr Charles Kelly
Bojidar Goranov
Professor Vinidh Paleri
| Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review | 2018 |
|
Dr Hans Sathasivam
James O'Hara
Dr David Meikle
Dr Charles Kelly
Dr Max Robinson
et al. | Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer | 2018 |
|
Dr Charles Kelly
| Small cell neuroendocrine carcinoma of the alveolar process of maxilla | 2018 |
|
JJ Wyatt
Dr Charles Kelly
Dr Hazel McCallum
| Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging–Only Radiation Therapy | 2018 |
|
JJ Wyatt
Dr Charles Kelly
Dr Hazel McCallum
| Investigating the generalisation of an atlas-based synthetic-CT algorithm to another centre and MR scanner for prostate MR-only radiotherapy | 2017 |
|
Dr Charles Kelly
| Chemotherapy: United Kingdom National Multidisciplinary Guidelines | 2016 |
|
Professor Vinidh Paleri
Dr Charles Kelly
| Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate | 2015 |
|
Professor Vinidh Paleri
Dr Charles Kelly
| Small cell neuroendocrine carcinoma of larynx: Case series and literature review | 2015 |
|
Professor Vinidh Paleri
Professor Alastair Greystoke
Dr Charles Kelly
| Spindle cell carcinoma of the head and neck region: Treatment and outcomes of 15 patients | 2015 |
|
Dr Charles Kelly
| Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study | 2014 |
|
Dr Joanne Patterson
Emerita Professor Elaine McColl
Professor Paul Carding
Anthony Hildreth
Dr Charles Kelly
et al. | Swallowing in the first year after chemoradiotherapy for head and neck cancer: Clinician- and patient-reported outcomes | 2014 |
|
Dr Ross Maxwell
Dr John Wilsdon
Dr Charles Kelly
| Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study | 2012 |
|
Professor Vinidh Paleri
Professor Paul Carding
Dr Sanjoy Chatterjee
Dr Charles Kelly
Emerita Professor Janet Wilson
et al. | Voice outcomes after concurrent chemoradiotherapy for advanced nonlaryngeal head and neck cancer: A prospective study | 2012 |
|
Dr Sanjoy Chatterjee
Dr John Wilsdon
Dr Judith Mott
Paddy Stevenson
Dr Ross Maxwell
et al. | Final Results of Vortigern Study: CT Versus Pet-CT Based Tomotherapy Voluming and Dose Escalation in Oropharyngeal Squamous Cell Carcinoma (ISRCTN 33175361, UKCRN ID: 08/h0907/127) [meeting abstract] | 2011 |
|
Dr Charles Kelly
Professor Vinidh Paleri
| Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer | 2010 |
|
Dr Sanjoy Chatterjee
Dr John Wilsdon
Dr Judith Mott
Paddy Stevenson
Dr Ross Maxwell
et al. | VortigERN: Variation of radiotherapy target volume definintion, dose to organs at risk (OAR), and clinical target volumes using anatomic (CT)versus combined anatomic and molecular imaging (PET-CT): Intensity-modulated radiotherpay delivered using a tomotherapy hi art machine | 2010 |
|
Dr Shaheel Chummun
Neil McLean
Dr Charles Kelly
| Mucoepidermoid carcinoma of the head and neck: A 13-year review | 2008 |
|
Dr Charles Kelly
| Radiotherapy for management of skin cancers in fibrodysplasia ossificans progressiva: A case report and review of the literature | 2008 |
|
Professor Vinidh Paleri
Dr Charles Kelly
| Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: A decision analysis model based on a systematic review | 2008 |
|
Dr Charles Kelly
Andrew Welch
Professor Vinidh Paleri
| The effect of comorbidity on quality of life during radiotherapy in head and neck cancer | 2008 |
|
Professor Vinidh Paleri
Dr Nick Steen
Dr Charles Kelly
| Comorbidity in nasopharyngeal carcinoma: A preliminary communication on the prevalence, descriptive distribution and impact on outcome | 2007 |
|
Professor Vinidh Paleri
Dr Nick Steen
Dr Charles Kelly
| Comorbidity in nasopharyngeal carcinoma: a preliminary communication on the prevalence, descriptive distribution and impact on outcome | 2007 |
|
Dr Charles Kelly
Professor Vinidh Paleri
| Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer | 2007 |
|
Dr Charles Kelly
Neil McLean
| Carcinoma ex benign pleomorphic adenoma of the parotid gland | 2005 |
|
Professor Nicholas Jakubovics
Dr Charles Kelly
| Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands | 2005 |
|
Professor Nicholas Jakubovics
Dr Charles Kelly
| Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors | 2005 |
|
Dr Charles Kelly
Neil McLean
| Multidisciplinary management of head and neck sarcomas | 2005 |
|
Dr Charles Kelly
| Symptom control and quality of life in people with lung cancer: A randomised trial of two palliative radiotherapy fractionation schedules | 2005 |
|
Dr Charles Kelly
| Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy - A multicenter open randomized phase III study | 2005 |
|
Dr Nick Steen
Dr Charles Kelly
Andrew Welch
Dr David Meikle
Emerita Professor Janet Wilson
et al. | Optimizing the assessment of quality of life after laryngeal cancer treatment | 2004 |
|
Sophia Stavrakakis
Neil McLean
Peter Hodgkinson
Dr Charles Kelly
| Microvascular histopathology in head and neck oncology | 2003 |
|
Neil McLean
Dr Charles Kelly
| Head and neck oncology: the UK experience. Who is publishing what? | 2002 |
|
Dr Shaheel Chummun
Neil McLean
Dr Charles Kelly
Dr Peter Dawes
Dr David Meikle
et al. | Adenoid cystic carcinoma of the head and neck | 2001 |
|
Dr Charles Kelly
| Result of two randomized trials comparing nolatrexed (Thymitaq (TM)) versus methotrexate in patients with recurrent head and neck cancer | 2001 |
|
Neil McLean
Dr Charles Kelly
| Cutaneous metastasis to the head and neck from colonic carcinoma | 2000 |
|
Neil McLean
Dr Charles Kelly
| Head and neck skin involvement by non-cutaneous head and neck cancers: Free flap reconstruction | 2000 |
|
Emeritus Professor Roger Francis
Dr Alexis Chuck
Dr Paul Crook
Dr Terence Daymond
Dr John Fordham
et al. | Management of osteoporosis in patients with hip fractures | 2000 |
|
Dr Charles Kelly
Neil McLean
| Trans-osseous passage of head and neck brachytherapy tubes | 2000 |
|
Dr Ramesh Rajentheran
Dr Charles Kelly
Malcolm Reed
Dr Anita Nolan
| Malignant transformation of oral lichen planus | 1999 |
|
Professor John Lunec
Emerita Professor Janet Wilson
Dr Charles Kelly
| Expression of cyclin dependent kinase inhibitors in laryngeal cancer | 1998 |
|
Neil McLean
Dr Charles Kelly
Dr Andrew Chippindale
| Malignant tumours of the parotid gland: A 12-year review | 1997 |
|
Dr Andrew Hall
Dr Charles Kelly
| Exercise testing soon after myocardial infarction: its relation to course and outcome at one year in patients aged less than 55 years | 1989 |
|
